ASHNA GOYAL: Open Payments
NPI 1598428708 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,413 in 120 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,784 · 2025 $2,413
Food & beverage: $2,321Education: $92
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $565 |
| Amgen Inc. | 24 | $332 |
| GlaxoSmithKline, LLC. | 22 | $298 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $271 |
| Regeneron Healthcare Solutions, Inc. | 7 | $197 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| CSL Behring | 4 | $111 |
| GENZYME CORPORATION | 4 | $106 |
| LEO Pharma Inc. | 5 | $103 |
| Optinose US, Inc. | 2 | $59 |
Products named: TEZSPIRE, DUPIXENT, AIRSUPRA, NUCALA, FASENRA, CUVITRU, EOHILIA, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
